Teva Pharmaceuticals

PARSIPPANY, N.J., and TEL AVIV, Israel, August 31, 2026 Teva Pharmaceuticals announced a shared commitment with the Trump Administration...

PARSIPPANY, N.J., August 19, 2026 Teva Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted its...

PARSIPPANY, New Jersey, USA & TEL AVIV, Israel – June 8, 2026 Teva Pharmaceuticals has unveiled new real-world and...

PARSIPPANY, N.J. and TEL AVIV, Israel, June 5, 2026 Teva Pharmaceuticals announced new real-world data demonstrating that treatment with...

PARSIPPANY, N.J. and TEL AVIV, Israel, June 5, 2026 Teva Pharmaceuticals has presented new real-world evidence demonstrating that treatment...

TEL AVIV, Israel & PARIS, May 21, 2026 Teva Pharmaceuticals and Medincell have announced that the European Medicines Agency...

PARSIPPANY, N.J. and TEL AVIV, Israel, May 18, 2026 Teva Pharmaceuticals has announced new findings from its ongoing IMPACT-TD...